Elmiron Lawsuit

Elmiron lawsuits have been brought forth by almost 800 people to date, with many more Elmiron lawsuits still pending in federal court. Elmiron is a prescription medication used to treat interstitial cystitis, which is chronic pain that affects the bladder and pelvic floor. 

Elmiron is the name brand for the drug pentosan polysulfate sodium (PPS), so you may likely have taken it if you suffer from interstitial cystitis. Elmiron lawsuits concern people who have experienced eye injury and blindness from taking Elmiron.

People who took Elmiron are suing Janssen Pharmaceuticals, owned by Johnson & Johnson because they developed maculopathy and vision problems that could lead to blindness. Elmiron lawsuits claim that Janssen did not properly warn doctors and patients of Elmiron’s devastating adverse side effects. 

Furthermore, plaintiffs maintain that Janssen knowingly withheld adverse reports demonstrating the drug’s dangerous defectiveness. People who file Elmiron lawsuits may be eligible for medical, pain, suffering, work loss, quality of life loss, and future care costs resulting from Elmiron’s harm and damage.

Federal agencies hold companies responsible for the products they produce and sell to the public. These agencies ensure that products will not cause environmental, mental, or physical harm to the people who use them. Product liability law is the legal process around who is responsible in situations that cause harm, as in the case of Elmiron. If you took Elmiron for two years or more and experienced vision problems, you might qualify for an Elmiron lawsuit.

You and your product liability attorney will meet to discuss your case and unique circumstances. You need results. An excellent legal team like the Stoy Law Group will ensure you get past this trying time in your life. We’ll ensure that companies like Janssen Pharmaceuticals own up to their mistakes and stop hurting people like you with their faulty products.

You might have questions about working with personal injury lawyers, or you may have some basic questions about Elmiron lawsuits. We’ve provided information for you here to help give you the information you need to move forward with your life.

Elmiron Lawsuit Settlement Amounts

In December of 2020, the Judicial Panel on Multidistrict Litigation ordered that all Elmiron lawsuits get consolidated into multidistrict litigation in New Jersey for pretrial administration. As such, there have been no jury verdicts or settlements. Like most class-action lawsuits, multidistrict litigation combines lawsuits with similar claims. From this group of claimants, both plaintiffs and defendants pick 4 to 5 cases that will serve as “bellwether trials.†

These are test trials that serve as a basis for negotiations. These cases are unlike class-action lawsuits in that each case gets treated as an individual claim. This is something to consider when bringing forth your case. We can help with a free case evaluation.

It may feel disappointing that Elmiron lawsuits haven’t been awarded any settlements yet, but attorneys have estimated there may be as many as 1,000 or more cases out there. You could be one of them. The first Elmiron lawsuits are scheduled for trial at the beginning of 2023, so there’s still time for you to act. 

Just remember that you’re not alone, and we can help. Attorneys are now taking cases for Elmiron lawsuits from people who took Elmiron for two or more years and experienced vision problems. If you took Elmiron from 2018 to the present, attorneys want to speak with you, especially.

Elmiron eye injury

What Is Retinal Maculopathy

People who took Elmiron for two years or longer may have experienced vision problems or retinal maculopathy for a period of up to one-year past treatment with Elmiron. We are sorry for your circumstances if this is you, but we are here to help you. We offer 100% free and confidential consultations.

Before you contact us, it would benefit you to know that retinal maculopathy is a disease concerning the macula region of the eye. The macula is the central portion of the retina. Maculopathy is a disease of the macula. Elmiron causes macular degeneration. Twenty-five percent of patients who took Elmiron have experienced eye injury and blindness caused by retinal maculopathy Elmiron induced. Research has shown that Elmiron is poison to the eyes!

Your retina is a thin layer of tissue at the back of your eye that converts light into images the brain recognizes as images. This is the act of sight. Any damage to the retina can cause permanent blindness and a loss of your eyesight. Sometimes, your vision is blurred, and other times there is a complete loss of sight. 

Researchers found that Elmiron causes over-pigmentation and yellow-orange deposits to form in the retinal pigment epithelium (RPE). It also causes a retinal detachment. When the retina detaches from its usual position, it has difficulty receiving light if it can receive any light at all. However, the full extent of Elmiron’s damage is unknown and may be potentially worse than estimated.

Just a few of the many symptoms of retinal maculopathy include:

  • Blurred vision
  • Blindness
  • Difficulty adjusting to bright or dark light
  • Difficulty seeing at night
  • Halo vision
  • Problems with vision focus
  • Problems reading
  • Reduced night vision
  • Vision impairment
  • Vision loss

Elmiron lawsuits concern a type of eye disease called pigmentary maculopathy, a degenerative disease of the eye. Pigmentary maculopathy is a rare disease linked to long-term use of the drug Elmiron. The macula is responsible for sharp and detailed vision, so people who experience symptoms of this disease caused by Elmiron have problems reading or have lost the ability to read.

People who used the drug long-term developed pigmented deposits in their macula that cause black circular spots in the field of sight and vision loss. This severely inhibits your activities of daily living and your quality of life on top of your pain and discomfort caused by your interstitial cystitis. You don’t need to suffer alone or without help. Elmiron lawsuits seek to rectify the harm caused by Elmiron by awarding you for damages.

Have There Been Any Elmiron Settlements?

There have not been any Elmiron settlements so far, but they are underway. You can be part of one. People who took Elmiron to treat interstitial cystitis filed Elmiron lawsuits against Janssen Pharmaceuticals after they suffered vision problems that could lead to blindness, including maculopathy. 

Several studies have linked Elmiron use to vision damage. Frequently, it has been hard for patients to connect their Elmiron use to it because the condition can be masked as age-related vision disease. However, Elmiron causes irreversible damage to the eye and generates a unique condition called pigmentary maculopathy, which can lead to blindness and for which there is no cure.

The first bellwether trials for Elmiron lawsuits are scheduled for early 2023, so you still have time to take action. You won’t owe us anything unless we win your case. We have a page that goes over how a contingency fee attorney work, if you are interested, 

Most personal injury lawyers charge between 33-40% if the case gets settled or won. Because there have been no Elmiron lawsuit settlements yet, it is impossible to state the settlement amount. However, costs for medical, pain, suffering, work loss, quality of life loss, and future care costs resulting from Elmiron’s harm and damage will be included in the settlement.

Did They Take Elmiron Off the Market?

No, Elmiron has not been taken off the market by the Food and Drug Administration (FDA). Elmiron wasn’t even labeled as causing pigmentary maculopathy until June of 2020! On June 16, 2020, the FDA approved a change to the Elmiron label that states that long-term use of Elmiron links with pigmentary maculopathy, which are pigmentary changes in the retina linked to eye injury and blindness. 

This is good news for you. Suppose you have experienced any symptoms of vision problems or loss and have been taking Elmiron for two years or longer. Contact us for a free consultation today.

Elmiron has not been recalled despite studies linking long-term use of Elmiron, or pentosan polysulfate sodium (PPS), to eye injury and blindness. Elmiron has been on the market since 1996, and it’s the only drug approved to treat the pain and discomfort associated with interstitial cystitis. 

There are a few other alternatives to Elmiron that are less effective. However, Janssen didn’t warn people about the risk of pigmentary maculopathy until the DFA approved the drug label warning in June of 2020. That’s a quarter-century of damage to many more victims than filing Elmiron lawsuits. You could be next.

How Much is the Elmiron Lawsuit?

Settlements like the Elmiron lawsuit have tiers or levels of payments to plaintiffs. The tiers get determined by the degree of severity of your injury due to Elmiron’s use long-term. It is too early in the litigation to say how much the settlement amount will be for each claimant. 

When you compare Elmiron lawsuits to other similar lawsuits. You can expect to receive somewhere in the range of 1 M or more in cases where the plaintiff has endured complete and permanent vision loss; these are tier 1 cases.

Some estimates are in the $300,000 to 600,000 range for injuries in tier 2 and 3 categories. Tier 2 eye injuries resulted in 40-75% vision loss to plaintiffs due to the long-term use of Elmiron. Tier 3 eye injuries are under this threshold. The payouts for those cases range from $75,000 to $250,000. Any injury to the eye is of serious consequence and severely impacts a person’s quality of life and activities of daily living.

Elmiron vision and eye problems

Elmiron Eye Lawsuit

Elmiron eye lawsuits have been brought forth by a large number of women since 1997 because the drug Elmiron has been shown by researchers to cause eye injury and blindness. The company that manufactures Elmiron is Janssen Pharmaceuticals, owned by Johnson & Johnson. 

Elmiron lawsuits claim that Janssen knew that Elmiron was known to cause pigmentary maculopathy and did not adequately warn patients or physicians of this known side-effect shown in as many as 25% of patients who took Elmiron for two years or longer. Most of these patients are women who suffer from an already debilitating condition. They used Elmiron to treat interstitial cystitis, which is chronic pain that affects the bladder and pelvic floor.

Women who took Elmiron suffered a second blow to their ability to function and find joy in life. Attorneys like the Stoy Law Group provide sound legal counsel and advice to people who are suffering from the adverse effects of long-term Elmiron use. On top of Elmiron eye damage and injury, these women suffer from interstitial cystitis, which profoundly impacts your quality of life. 

Symptoms of interstitial cystitis include feeling the need to urinate immediately and all the time, needing to urinate often, and pain during sex. It is associated with depression and lower quality of life and is similar to the pain associated with end-of-life kidney failure. Men can suffer from this condition, too, although it is more prevalent in women and is five times more common in women than in men.

We estimate that 0.5 of people in the United States are afflicted with interstitial cystitis. That’s almost 12 million people! Elmiron is one of the most common treatments for interstitial cystitis, there are likely many more victims who need representation in Elmiron lawsuits.

Elmiron Eye Damage Symptoms

Elmiron is toxic to retinal tissue in the human eye and causes pigmentary maculopathy. Elmiron causes eye damage to 25% of the patients who use it. Elmiron lawsuits concern eye damage symptoms including partial or total loss of vision, a gradual loss of central vision, pigmentary maculopathy, difficulty reading, difficulty adapting to dim light, and difficulty seeing out of one or both eyes. The progression may be slow, or it may take several years.

In the beginning, you may notice a dark spot when you look straight ahead that grows and expands over time. You may also experience vision distortion, which is called metamorphopsia. When you have this condition related to maculopathy, objects seem deformed like a mirror in a funhouse. You simply cannot function in life. You certainly can’t drive a car. 

Other symptoms may include hallucinations, such as flashing lights. You may also experience blurred vision or a loss of color and contrast. You may have difficulty adjusting to darkness or bright light. You are experiencing irreversible damage to your macula, which is the central portion of the retina.

You need your retina to convert light into images your brain recognizes. When your retina is damaged, it can cause permanent blindness and a loss of your eyesight. People who used Elmiron for many years experienced a partial or complete loss of eyesight. The longer you use Elmiron, the higher your risk of Elmiron-induced injury like pigmentary maculopathy. Contact us today if you have experienced flashes of light, blurred or distorted vision, muted colors, changes in your eye color, dark spots, blind spots, or floaters.

What is the Lawsuit Against Elmiron?

Recent studies have linked Elmiron to vision damage and loss, including pigmentary maculopathy. Despite these research findings, Elmiron is still on the market, and 25% of the people who take it will develop severe and irreversible eye problems. Elmiron lawsuits claim people who took Elmiron for between six months to two years developed maculopathy and vision problems that could lead to blindness. 

Janssen did not adequately warn doctors and patients of Elmiron’s devastating adverse side effects, and plaintiffs maintain that Janssen knowingly withheld the reports that demonstrated its dangerous defectiveness. Some even argue whether it is adequate to treat interstitial cystitis and question whether you should prescribe it at all.

Anyone who files an Elmiron lawsuit will consolidate their case into an MDL class action lawsuit. You could file an Elmiron lawsuit if you took Elmiron long-term and experienced vision impairment, macular degeneration, and vision loss. 

People who file Elmiron lawsuits may be eligible for costs resulting from Elmiron’s harm and damage. Elmiron is the only known cause of pigmentary maculopathy, so if this is your diagnosis and you have been taking Elmiron, contact us today to schedule a free case evaluation. You are likely due to an award due to eye damage caused by Elmiron. The evidence is that conclusive.

Elmiron Class Action Lawsuit

In December of 2020, the New Jersey Supreme Court granted a motion to consolidate Elmiron lawsuits into multi-district litigation (MDL) for pretrial proceedings before a single judge. The Elmiron class-action lawsuit settlement will likely be resolved around the beginning of January 2023. 

Suppose you or a loved one were diagnosed with vision problems related to the retina or macula or with a rare eye condition called pigmentary maculopathy. In that case, you might qualify to join this Elmiron lawsuit. 

There are qualified attorneys ready to work on your case at Story Law Group, PLLC, and you won’t pay a dime unless we win your case. With a class action lawsuit like the Elmiron lawsuit, you are likely to get a monetary award for the eye damage and injury that you seek.

The Elmiron MDL litigation got established under Judge Brian Martinotti for the Elmiron class-action lawsuit. There are already over 800 Elmiron lawsuits in federal courts that get consolidated in the MDL. You could be one of them. You should act now if you have an eye injury due to taking Elmiron. 

There may be a statute of limitations in your state. However, the public’s knowledge of Elmiron’s damage is relatively new, so you may still be able to prove that you didn’t know the connection between Elmiron and retinal maculopathy. The statute of limitations begins when Elmiron causes pigmentary maculopathy. Then you have a limited time to act on a free case evaluation.

Elmiron Lawsuit Criteria

If you’ve been diagnosed with pigmentary maculopathy, then you qualify to file an Elmiron personal injury lawsuit. To be eligible for an Elmiron lawsuit, you must meet specific criteria for material eye damage, and you must have taken Elmiron for at least one year according to new standards from the MDL court. Janssen Pharmaceuticals and Johnson & Johnson knowingly withheld adverse reports demonstrating Elmiron eye injury and failed to inform doctors and the public.

Suppose you were not diagnosed with pigmentary maculopathy. In that case, you might still qualify to file an Elmiron lawsuit if you took Elmiron and received a diagnosis from eye injury resulting in vision impairment or blindness and loss. It’s best to contact us even if you’re not sure. We can help you with a free case evaluation, and we offer contingency-fee-based. That means you won’t pay a dime if we don’t win your case.

If you’ve taken Elmiron and can you answer yes to the following questions, then you should contact us for a free case evaluation today!

  • Have you been diagnosed with retinal damage or other eye damage?
  • Have you received a diagnosis of pigmentary maculopathy, retinopathy, scotoma, and any other type of macula or retinal disorder?
  • Have you experienced blurred vision, halo vision, vision loss, or unilateral or bilateral blindness?
  • Have you seen spots or flashes of light?

Elmiron Lawsuit Lawyers

Our qualified Elmiron lawsuit lawyers can help you seek justice and restitution. We’ve received many positive reviews from our clients seeking justice and restitution for personal injury. We will go to great lengths to protect you from personal injury. We’ve been holding negligent drug companies accountable for their faulty products. Today, you can help other victims and yourself by joining this class action lawsuit.

Elmiron Eye Attorney

If you can’t come to our office, our team can come to you! We’re located in downtown Ft. Worth, Texas, and if you can’t meet us here, why don’t you complete this case evaluation form online to get started? You won’t pay a thing unless we win your case! We have a qualified and hard-working legal team ready to fight for you!

Maculopathy and Elmiron

In 2018, Dr. Nieraj Jain, who worked at the Emory Eye Center in Atlanta, Georgia, noticed that 6 of their patients all had abnormal damage to their retinas and were diagnosed with pigmentary maculopathy. These patients were seen by the Center from 2015 to 2017. Dr. Jain and a team of researchers noticed that all of their patients had used the drug Elmiron for a median number of 16 years. 

They issued a warning call and a report on the link between chronic exposure to Elmiron and the development of pigmentary maculopathy that the American Academy of Ophthalmology published in the November issue of Ophthalmology in 2018. In 2019, one of the researchers issued an update to show that ten patients had been diagnosed with pigmentary maculopathy.

Pigmentary maculopathy is a new disease that develops from chronic exposure to Elmiron, the drug pentosan polysulfate sodium (PPS). There’s only a simple mention of vision problems as an “other†medical problem on the Mayo Clinic’s website, and a search for “pigmentary maculopathy†yielded no results. 

It’s that new. We consider pigmentary maculopathy a novel disease, meaning that it has not been previously recorded. The researchers proved that Elmiron was the only cause of pigmentary maculopathy on record, meaning that it is the cause of the disease beyond a reasonable doubt. You know the cause of your eye injury, and we’re here to help you win your Elmiron lawsuit.

When Did the Elmiron Lawsuit Start?

Tina Pisco filed the first Elmiron lawsuit on May 4, 2020, claiming that the drug caused her to develop maculopathy. She began taking it in 2012, and her vision began to deplete over six years since she began treatment with Elmiron. 

Pisco was diagnosed with permanent retinal injury in both eyes in 2019 and sued Janssen Pharmaceuticals and Johnson & Johnson. Pisco’s suit alleges that the companies knew of Elmiron’s significant and material risks to eyes never disclosed to the medical community or the public.

In June of 2020, Valerie Hull filed an Elmiron lawsuit against Janssen and Johnson & Johnson because she suffers from pigmentary maculopathy, including a loss of night vision and changes in the pigment of her eyes and severe vision degradation. 

Hull is known as “Patient Zero†because her case was studied by researchers in the 2018 Emory Eyecare study that demonstrated that Elmiron is toxic to the retinal tissue in the eyes. The groundbreaking report further showed that long-term use of the drug pentosan polysulfate sodium (PPS) caused pigmentary maculopathy. This report has been the basis of Elmiron lawsuits.

Contact Stoy Law Group, PLLC.

The Stoy Law Group has years of experience providing sound legal counsel in difficult times. If you need advice regarding the Elmiron lawsuit or are searching for the right contingency fee lawyer, we are happy to evaluate your case. Contact us today for a free consultation.